oncologysupply.com
New Account
Sign In
Logout
☰
˟
▼
Contact
▼
Customer Service
1-800-633-7555
Email
Nucleus Help Desk
1-877-224-9692
Email
Online Help
1-877-757-7954
Email
Accounting
1-888-877-8430
Email
Join ION Solutions
1-888-536-7697 ext. 3103
Email
Additional Contacts
Account
▼
Admin
View Account
My Profile
Order
Rebates
Reports
Invoices
Favorites
Protocol Analyzer
Nucleus Inventory
Nucleus Connect
Catalog
Site Content
LOGIN FAILED - Invalid User Name / Password. Please Try Again
You have been logged out. Thank you
This is a warning feedback message
Precision Medicine Center
Home
Precision Medicine Center
Precision Medicine Center
Precision by Tumor
Precision by Partner
Precision Education
Precision for Patients
Additional Resources
Precision by Tumor
Precision by Tumor
Select a tumor type below to view its testing recommendations.
Breast Cancer
Breast Cancer
NSCLC
NSCLC
Colorectal
Colorectal
Gastric
Gastric
Gastrointestinal
Gastrointestinal
Genitourinary
Genitourinary
Head & Neck
Head & Neck
Lymphoma
Lymphoma
Multiple Myeloma
Multiple Myeloma
Leukemia
Leukemia
Rare Disease
Rare Disease
Ovarian Cancer
Ovarian Cancer
Testing for Hereditary Risk Assessment
Diagnostic Testing
Prognostic Testing
Testing for Metastatic Disease
Adenocarcinoma, NOS NSCLC, or Large Cell Lung Cancer:
Newly Diagnosed, Early Stage Disease
Advanced/Metastatic Disease at Initial Diagnosis
Advanced/Metastatic Disease at Time of Disease Progression
Advanced/Metastatic Disease at Time of Disease Progression After Prior Therapy
Squamous NSCLC:
Newly Diagnosed, Early Stage Disease
Advanced/Metastatic Disease
Diagnostic Testing for Stage IIB-IIIA Patients
Diagnostic Testing for All Patients with Metastatic Disease
Diagnostic Testing for Second Line Treatment with I/O Drugs
Genetic High Risk Patients
GI-Hereditary Risk Assessment (Gastric Cancer)
GI-Locally Advanced/Recurrent, Metastatic (Gastric Cancer-Adenocarcinoma)
Gastrointestinal Stromal Tumors (GIST)
Prostate Cancer
Bladder Cancer
Nasopharynx, Nasopharyngeal & Oropharynx
Mantle Cell & Follicular Lymphoma
Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL) & CD5+ B-cell Lymphoproliferative Disorders
Diffuse Large B-Cell Lymphoma (DLBCL)
Lymphoplasmacytic Lymphoma (LPL), Marginal Zone Lymphoma, and Hodgkin’s Lymphoma
Multiple Myeloma
B cell-Acute Lymphoblastic Leukemia-Adult
T cell-Acute Lymphoblastic Leukemia-Adult
MDS/Acute Myelogenous Leukemia
Chronic Myelogenous Leukemia
Hairy Cell Leukemia
Rare Disease
Ovarian Cancer
Precision by Partner
Astellas
FLT3m+ R/R AML Official Physician Website
FLT3m+ R/R AML Core Product Guide
Retesting for FLT3 mutations in AML
Full Prescribing Info, Including BOXED WARNING
View More AstraZeneca Resources
Laboratory Developed Tests
Pathologist-Initiated Testing
Prostate Cancer Testing Leave Behind
AZ Oncology ID: Informing treatment through precision medicine
Request more information or a visit from an AZ representative
Integrated Oncology
Oncology & Pathology Comprehensive Test Services
Predictive Guide for Precision Medicine
Featured Broad Based Biomarker NGS Tests
Resolution ctDx Lung: Liquid Biopsy for NSCLC
OmniSeq Advance: Somatic & Immune Biomarker Test for Solid Tumors
IntelliGEN Myeloid: Somatic Biomarker Test for Hematologic Malignancies
Biomarker Tests for Immunotherapy Selection
Genentech
Actionable Biomarkers in Multiple Tumor Types (NTRK, MSI, TMB, and mTMB)
Testing Biomarkers in Breast Cancer (HER2, PD-L1)
Testing Biomarkers in Gastroesophageal Adenocarcinoma (HER2)
Biomarker Profiling in Lung Cancer Characterization (ROS1, ALK, EGFR)
Molecular Pathways - Cancer Target Overviews
Molecular Pathways - Immune Target Overviews
Biomarker Testing Educational Resource
Learn about testing for NTRK
Learn about testing for PD-L1 in TNBC
Blueprint Medicines
Blueprint Medicines Overview
Access and Reimbursement Toolkit
Biomarker Testing NSCLC Patient Fact Sheet
RET + NSCLC Patient Fact Sheet
RET + NSCLC Disease Education Flashcard
Systemic Mastocytosis Overview
AYVAKIT - Patient Brochure
AYVAKIT - Patient Management Guide
GAVRETO HCP Now Approved NSCLC Product Brochure
GAVRETO NSCLC Patient Brochure
Myriad
Hereditary Cancer Testing Matters
BRACAnalysis CDx Pancreatic Postcard
BRACAnalysis CDx Patient Education Tool
BRACAnalysis CDx Sales Aid
ONC Virtual Testing Request Cover Sheet
Virtual Ordering Overview
Virtual Ordering Options Saliva and Blood
Introducing myGeneHistory
myRisk: Genetic Testing Criteria
Myriad Promise: Expanded Access Postcard
Myriad is ION's Preferred Partner for Best-In-Class Genetic Testing & Services
Myriad Announces the Preferred ION Program
Stemline
BPCDNinfo.com
ELZONRIS.com/hcp
ELZONRIS Dose Preparation Instructions
ELZONRIS Dose Administration Instructions
Pre-Dose Prep Materials
BPDCN Patient Journey
ELZONRIS MOA Video
Product Preparation Video
Dose Administration Video
CLS Management Video
ELZONRIS Patient Brochure
NEJM “Tagraxofusp in BPDCN” Article
ELZONRIS Product Specification Sheet
Precision Education
Breast Cancer
Breast Cancer
NSCLC
NSCLC
Genitourinary
Genitourinary
Laboratory Developed Tests
NSCLC III:
Staging and Resectability
NSCLC IV:
Best Practices in Implementing Broad Biomarker Testing for mNSCLC
Managing EGFR Mutation-Positive mNSCLC: Where are TKIs and IO Approved?
Testing Options for Broad Biomarker Profiling in Patients with mNSCLC
Prostate Cancer Testing Leave Behind
Laboratory Developed Tests
Pathologist-Initiated Testing
Precision for Patients
Precision for Patients
About Lung Cancer Staging
NSCLC Stage I-II
NSCLC Stage III
NSCLC Stage IV
About Treatments
Chemotherapy
Immunotherapy
Targeted Therapy
About What to Expect after Diagnosis
Navigating Lung Cancer: The Patient Journey
About Testing
Precision Medicine & What It Means For You
5 Things to Know About Lung Cancer Biomarker Testing Results
Biomarker Conversation Starter
Why Talk to Your Doctor About Comprehensive Biomarker Testing?
About Testing and Treatments
Biomarker Testing
Clinical Trials
Chemotherapy
Immunotherapy
Targeted Therapy
About Types and Stages of Lung Cancer
Lung Adenocarcinoma
NSCLC Stage I
NSCLC Stage II
NSCLC Stage III
NSCLC Stage IV
Small Cell Lung Cancer
Squamous Cell Lung Cancer
Additional Resources
News
Meet the Team
Archives
COVID-19 Presents an Opportunity for Precision Medicine to Play Expanded Role in Care
Next-Generation Sequencing Can Improve Treatment Decisions, But Community Uptake Remains Delayed
Garbage In, Garbage Out
Biomarkers Drive Advances in Drug Therapy
Best Practices for Effective Genomic Testing in Community Oncology
Preanalytics and Precision Pathology
Precision Medicine: Options for Accessing Targeted Therapies
Determining If a Somatic Tumor Mutation Is Targetable and Options for Accessing Targeted Therapies
Precision Medicine Panel
ION Precision Medicine Team
Contact Us
2019 Precision Oncology Meeting Archives
Precision Medicine Summit Archives
Webcast Series: Breast Cancer Testing Recommendations
Research Opportunities
Upcoming Events
Article by Kashyap Patel and Natasha Clinton:
Next-Generation Sequencing Can Improve Treatment Decisions, But Community Uptake Remains Delayed
Article:
Best Practices for Effective Genomic Testing in Community Oncology
Article by Carolyn Compton:
Preanalytics and Precision Pathology
Article by Carolyn Compton:
Garbage In, Garbage Out
Article:
Precision Medicine: Options for Accessing Targeted Therapies
Article:
Determining If a Somatic Tumor Mutation Is Targetable and Options for Accessing Targeted Therapies
Article:
Biomarkers Drive Advances in Drug Therapy
Precision Medicine Panel
ION Precision Medicine Team
Contact Us
Precision Medicine Summit Archives
2019 Precision Oncology Meeting Archives
Webcast Series:
Breast Cancer Testing Recommendations